Home

סגסוגת מרתף כך camillo porta oncologo היררכיה למשוך לקבל

Loop | Camillo Porta
Loop | Camillo Porta

Sorafenib as first- or second-line therapy in patients with metastatic  renal cell carcinoma in a community setting
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting

Carcinoma renale a ESMO 2021, uno sguardo d'insieme - OncoInfo
Carcinoma renale a ESMO 2021, uno sguardo d'insieme - OncoInfo

Adult Urology | Journal of Urology
Adult Urology | Journal of Urology

Application of the Meet-URO score to metastatic renal cell carcinoma  patients treated with second- and third-line cabozantinib
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib

Loop | Camillo Porta
Loop | Camillo Porta

Tweets with replies by Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter
Tweets with replies by Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter

JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion)  Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome  Intratumoral Heterogeneity: The Meet-Uro 18 Study | HTML
JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study | HTML

Camillo Porta - Medical Doctor - Università degli Studi di Bari | LinkedIn
Camillo Porta - Medical Doctor - Università degli Studi di Bari | LinkedIn

Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter
Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter

Loop | Camillo Porta
Loop | Camillo Porta

Daniel CASTELLANO | Hospital Universitario 12 de Octubre, Madrid |  12OCTUBRE | Medical Oncology Department
Daniel CASTELLANO | Hospital Universitario 12 de Octubre, Madrid | 12OCTUBRE | Medical Oncology Department

thumbnail
thumbnail

Adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica  I.R.C.C.S. Policlinico San Matteo, Pavia. - ppt download
Adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia. - ppt download

Gaetano PEZZICOLI | Medical Doctor | Doctor of Medicine | Università degli  Studi di Bari Aldo Moro, Bari | Università di Bari | Dipartimento di  Scienze Biomediche ed Oncologia Umana (DIMO)
Gaetano PEZZICOLI | Medical Doctor | Doctor of Medicine | Università degli Studi di Bari Aldo Moro, Bari | Università di Bari | Dipartimento di Scienze Biomediche ed Oncologia Umana (DIMO)

Le nuove terapie contro il tumore al rene - YouTube
Le nuove terapie contro il tumore al rene - YouTube

Natural History of Malignant Bone Disease in Renal Cancer: Final Results of  an Italian Bone Metastasis Survey | PLOS ONE
Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey | PLOS ONE

Francesco ATZORI | Attending Phisician | Doctor of Medicine | Università  degli studi di Cagliari, Cagliari | UNICA | Azienda  Ospedaliero-Universitaria di Cagliari
Francesco ATZORI | Attending Phisician | Doctor of Medicine | Università degli studi di Cagliari, Cagliari | UNICA | Azienda Ospedaliero-Universitaria di Cagliari

Camillo Porta - insalutenews.it
Camillo Porta - insalutenews.it

Policlinico, Camillo Porta è il nuovo responsabile dell'UOC di Oncologia
Policlinico, Camillo Porta è il nuovo responsabile dell'UOC di Oncologia

Prof. Camillo Porta – Epidemiologia del Carcinoma Renale a Cellule Chiare -  YouTube
Prof. Camillo Porta – Epidemiologia del Carcinoma Renale a Cellule Chiare - YouTube

Loop | Camillo Porta
Loop | Camillo Porta

Nicola SILVESTRIS | Full professor | Professor | Università degli Studi di  Messina, Messina | UNIME - Page 4
Nicola SILVESTRIS | Full professor | Professor | Università degli Studi di Messina, Messina | UNIME - Page 4

Sorafenib as first- or second-line therapy in patients with metastatic  renal cell carcinoma in a community setting | Future Oncology
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting | Future Oncology

Medical Oncology - ISPA
Medical Oncology - ISPA

Alessandro RIZZO | Medical Doctor | Ospedale Oncologico "Giovanni Paolo II"  di Bari, Bari | IRCCS Bari | Department of Medical Oncology
Alessandro RIZZO | Medical Doctor | Ospedale Oncologico "Giovanni Paolo II" di Bari, Bari | IRCCS Bari | Department of Medical Oncology

Giampietro GASPARINI | Managing Director | Oncology
Giampietro GASPARINI | Managing Director | Oncology